Results 41 to 50 of about 513,714 (276)

Generics designate kinds but not always essences

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2019
Significance How people reason about “kinds” (richly structured categories with high inductive potential) is at the heart of theories of cognition. One theory characterizes people as biased to essentialize, concluding that people are biased to infer that
Alexander Noyes, F. Keil
semanticscholar   +1 more source

Non-equivalence of antibiotic generic drugs and risk for intensive care patients [PDF]

open access: yes, 2013
Background: The underlying axiom in applying generic drugs is the equivalence of their active ingredient with the (usually more expensive) innovator product, an all-embracing statement with the insidious result that physicians assume that the generic ...
Reshetnykov, Mykhaylo   +4 more
core   +1 more source

Trends in pharmaceutical expenditure in the Taiwan National Health Insurance database at different hospital levels

open access: yesJournal of Comparative Effectiveness Research, 2022
Aim: This study aimed to understand themedication usage among different hospitals in Taiwan. Materials & methods: The NHI claims database consisting of claims prescription drugs in Taiwan was used to determine drug prescriptions in different hospitals.
Ching-Hu Chung
doaj   +1 more source

Accessibility of essential anticancer medicines for children in the Sichuan Province of China

open access: yesFrontiers in Public Health, 2022
BackgroundCompared with high-income countries, the survival rate of childhood cancer is lower in low- and middle-income countries. Access to essential anticancer medicines is an indispensable component of pediatric cancer treatment, which is still a big ...
Zhe Chen   +35 more
doaj   +1 more source

Drug Import Replacement Is a Perspective Direction of the Development of Russian Economy

open access: yesУправленческое консультирование, 2018
The development of the domestic pharmaceutical industry as a science-intensive and hightech sector of the country’s economy is, among other things, a pledge of the drug safety of the state, especially in the conditions of a modern complex political ...
K. D. Grigorieva
doaj   +1 more source

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique

open access: yesRevue de la Régulation, 2015
The pharma has a particular significance given the challenges it involves for public health, economics, politics and ethics. The medicines production is therefore subject to multiple and complex regulations, both national and international. While some of
Philippe Abecassis, Nathalie Coutinet
doaj   +1 more source

Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study

open access: yesJournal of Family Medicine and Primary Care, 2020
Background: Generic drugs are low-cost alternatives to branded drugs. The government of India is encouraging physicians to prescribe the generics to decrease out-of-pocket expenditure of health care.
Jaykaran Charan   +5 more
doaj   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

open access: yesFrontiers in Pharmacology, 2014
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilisation. However, considerable variation in their use and prices.
Brian eGodman   +30 more
doaj   +1 more source

Home - About - Disclaimer - Privacy